Before UFC middleweight Tim Kennedy was booked to battle Lyoto Machida there was a good deal of discussion on the possibility of the Strikeforce veteran squaring off against Vitor Belfort. However, Belfort was ultimately scheduled to face Dan Henderson after turning the clash with Kennedy down, and now the world knows why. Though it was believed Belfort didn’t want to risk his spot as top contender at 185 pounds, according to Kennedy, “The Phenom” actually didn’t want to compete outside of the friendly confines of his home country where scrutiny surrounding Testosterone Replacement Therapy isn’t as steep.
“His requirement to fight me was to fight me in Brazil,” revealed Kennedy in a conversation with Bleacher Report. “If I get a call to fight, I’m told it’s at this time, at this place, and I accept. I don’t go around being like ‘Well, I’m only going to fight so and so if we meet in Austin, Texas.’ Fight clean, stop using steroids.”
“If you have a guy who can only fight in a scenario where he’s injecting synthetic testosterone into his body, he shouldn’t be fighting,” he continued. “This is mixed martial arts, (which involves) integrity, legacy, discipline … this is not Mark McGwire baseball; he almost killed the sport of baseball. Somebody needs to come to grips that this is damaging the sport.”
With Henderson also subscribing to the controversial practice of TRT, Kennedy feels the UFC has a match made in PED-heaven.
“I wonder who is going to have higher testosterone levels during their fight camp,” he asked rhetorically. “The real competition for those two is who is going to have the highest testosterone levels during the fight camp. Just take their testosterone levels from four weeks out, and that’s the winner of the fight, no reason for these guys to even meet in the cage.”
Kennedy has long been an outspoken opponent of TRT. Fortunately, he only has to focus on his meeting with Machida at UFC Fight Night 31 instead of the influence testosterone will have on the tilt. Fans can catch their clash on FOX Sports 1 this November 6.
Front-Page Photo Credit: Jayne Kamin-Oncea-USA TODAY Spor